erythrosine has been researched along with sorafenib in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byeon, SH; Chung, EJ; Koh, HJ; Lee, JH; Lim, HJ; Yoo, S | 1 |
| Agard, DA; Duan, D; Elnatan, D; Logie, J; McLaughlin, CK; Shoichet, BK; Shoichet, MS; Torosyan, H | 1 |
| Almeida, PV; Correia, A; Herranz-Blanco, B; Hirvonen, J; Mäkilä, E; Salonen, J; Santos, HA; Shahbazi, MA; Shrestha, N | 1 |
3 other study(ies) available for erythrosine and sorafenib
| Article | Year |
|---|---|
Inhibition of choroidal neovascularisation in mice by systemic administration of the multikinase inhibitor, sorafenib.
Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Benzenesulfonates; Blotting, Western; Choroidal Neovascularization; Dextrans; Dose-Response Relationship, Drug; Female; Fluoresceins; Mice; Mice, Inbred C57BL; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib | 2009 |
Internal Structure and Preferential Protein Binding of Colloidal Aggregates.
Topics: Bacterial Proteins; beta-Lactamases; Colloids; Coloring Agents; Congo Red; DNA; Dynamic Light Scattering; Estradiol; Fluoresceins; Fulvestrant; Niacinamide; Peptides; Phenylurea Compounds; Protein Binding; Protein Folding; Proteins; Ribosomal Proteins; Scattering, Small Angle; Sorafenib; Trypsin; Trypsin Inhibitors; X-Ray Diffraction | 2017 |
Intracellular responsive dual delivery by endosomolytic polyplexes carrying DNA anchored porous silicon nanoparticles.
Topics: Antineoplastic Agents; Cell Line; Click Chemistry; Cross-Linking Reagents; Delayed-Action Preparations; DNA; Drug Liberation; Fluoresceins; Fluorescent Dyes; Humans; Maleic Anhydrides; Nanocomposites; Nanoparticles; Niacinamide; Oxidation-Reduction; Phenylurea Compounds; Polyethyleneimine; Polyvinyls; Porosity; Silicon; Sorafenib | 2017 |